Global Bioenergies

Equities

ALGBE

FR0011052257

Advanced Medical Equipment & Technology

Real-time Euronext Paris Other stock markets 06:08:33 2024-05-23 am EDT			5-day change	1st Jan Change
1.862 ^EUR	+0.11%		+2.53%	-7.82%

Apr. 09	Global Bioenergies Receives EUR70 Million Indicative Orders for New Plant	MT
Mar. 06	Global Bioenergies SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Global Bioenergies Names John Pierce as Chairman of its Board of Directors

September 01, 2015 at 01:31 am EDT

Global Bioenergies announced that John Pierce has been appointed as the new Chairman of its board of directors. John Pierce is an American veteran in the field of Industrial Biology and was until recently the Chief Bioscientist at BP plc (British Petroleum).

Latest news about Global Bioenergies

Global Bioenergies Receives EUR70 Million Indicative Orders for New Plant	Apr. 09	MT
Global Bioenergies SA Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 06	CI
Global Bioenergies Partners with Shell on More Focused Development of Low-carbon Road Fuels	Jan. 18	MT
Global Bioenergies SA Announces Board Changes	Jan. 17	CI
Global Bioenergies: financial visibility extended	Nov. 16	CF
Global Bioenergies Hires Chief Business Officer	23-10-19	MT
Global Bioenergies Announces the Appointment of Martin Stephan as Chief Business Officer	23-10-19	CI
Global Bioenergies Secures EUR16 Million Government Funding for Biosourced Isobutene Plant	23-10-04	MT
Global Bioenergies: disappointment after half-year results	23-09-20	CF
Global Bioenergies SA Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-19	CI
Global Bioenergies Launches Isonaturane® 16, Its Second Cosmetic Ingredient	23-03-30	CI
Global markets live: Blackberry, Meta Platforms, Rivian, GM...	23-03-07
Global Bioenergies: capital increase, share price falls	23-03-07	CF
Global markets live: Airbus, Walmart, Meta, Home Depot...	23-02-21
Global Bioenergies: research contract extended with Shell	23-02-21	CF
Global Bioenergies, Shell Extend Renewable Road Fuels R&D Deal	23-02-21	MT
Global Bioenergies Successfully Hits Milestone in Shell Collaboration and Signs Follow-On Agreement	23-02-21	CI
Global Bioenergies: significant sales in 2022	23-02-14	CF
Global Bioenergies SA Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-14	CI
Global Bioenergies Scales Up Production at Pomacle Commercial Unit	22-12-06	MT
Global Bioenergies Announces the Successful Scale-Up of Production At Its Pomacle Commercial Unit	22-12-06	CI
Shell Teams Up With Global Bioenergies to Develop Low-Carbon Road Fuels	22-11-14	MT
Global Bioenergies Agrees Collaboration with Shell in the Development of Low Carbon Road Fuels	22-11-14	CI
Global Bioenergies Renews Equity Line With Kepler Cheuvreux	22-11-11	MT
Global Bioenergies Jumps 7% on Completion of Residual Wood Conversion Project	22-09-22	MT

Chart Global Bioenergies

Duration

Period

More charts

Company Profile

Global Bioenergies substitutes products of fossil origin with products of natural origin. In their quest for naturalness without compromising on performance, the cosmetics players are the Company's first customers. By 2027, Global Bioenergies will be operating its innovative process in a large-scale plant. By 2030, the Company plans to become a leader in the huge emerging market for sustainable aviation fuels, in order to fight against global warming.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-09-17 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Global Bioenergies

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.86 EUR

Average target price

2.6 EUR

Spread / Average Target

+39.78%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
GLOBAL BIOENERGIES	-7.82%	36.54M
THERMO FISHER SCIENTIFIC	+11.31%	226B
DANAHER CORPORATION	+15.50%	198B
INTUITIVE SURGICAL, INC.	+18.83%	142B
BOSTON SCIENTIFIC CORPORATION	+30.38%	111B
SIEMENS HEALTHINEERS AG	+2.70%	65.26B
EDWARDS LIFESCIENCES CORPORATION	+18.31%	54.36B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.96%	50.94B
AGILENT TECHNOLOGIES, INC.	+9.95%	44.8B
GE HEALTHCARE TECHNOLOGIES INC.	+4.27%	36.8B

Other Advanced Medical Equipment & Technology